LABL Stock News 34.08 05/13/2014 15:14:22 Multi-Color Corp (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Multi-Color Corp (LABL) 34.08 $LABL

Multi-Color Corporation Declares Quarterly Dividend
Thomson Reuters ONE - Thu May 08, 7:31AM CDT
Cincinnati, OH - May 8, 2014 - Multi-Color Corporation (NASDAQ:LABL) announced today that its Board of Directors declared the Company's quarterly cash dividend for the first quarter of fiscal year 2015. The dividend is a payment of five cents per common share, payable June 2, 2014, to shareholders of record at the close of business on May 19, 2014.

Weakness Seen in Multi-Color (LABL) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 7:58AM CST
One underperforming stock that you may want to consider dropping is Multi-Color Corp. which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year

Multi-Color Corp. (LABL) in Focus: Stock Loses 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 7:33AM CST
Multi-Color Corp. shares dropped over 7% yesterday, continuing its downward trend as the stock is now down almost 9% since last month

Nasdaq stocks posting largest percentage decreases
AP - Tue Feb 04, 12:31PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Multi-Color Corporation Releases Third Quarter Earnings
Thomson Reuters ONE - Tue Feb 04, 7:30AM CST
CINCINNATI, OHIO, February 4, 2014 - Multi-Color Corporation (NASDAQ: LABL) today announced third quarter fiscal 2014 results.

Multi-Color Corporation Announces Di-Na-Cal Labels Acquisition
Thomson Reuters ONE - Mon Feb 03, 3:30PM CST
CINCINNATI, OHIO -February 3, 2014 - Multi-Color Corporation (NASDAQ: LABL) has acquired the Di-na-cal label business from Graphic Packaging International, Inc., effective immediately.

Multi-Color Corporation Announces Date of Third Quarter Fiscal Year 2014 Financial Results Conference Call and Webcast
Thomson Reuters ONE - Fri Jan 24, 7:00AM CST
CINCINNATI, OHIO, January 23, 2014 -- Multi-Color Corporation (NASDAQ:LABL) will announce Third Quarter Fiscal Year 2014 financial results on Tuesday, February 4, 2014 at 8:30 a.m. (ET) and hold its quarterly conference call on Tuesday, February 4, 2014 at 10:00 a.m. (ET) to discuss the news release.

Insiders Were Right: LABL Makes New 52-Week High
MarketNewsVideo.com - Tue Oct 29, 3:11PM CDT
In trading on Tuesday, shares of Multi-Color Corp. touched a new 52-week high of $35.75/share.

Multi-Color Shares Up 39.1% Since SmarTrend's Buy Recommendation (LABL)
Comtex SmarTrend(R) - Wed Aug 28, 9:42AM CDT
SmarTrend identified an Uptrend for Multi-Color (NASDAQ:LABL) on December 4th, 2012 at $22.97. In approximately 9 months, Multi-Color has returned 39.09% as of today's recent price of $31.95.

Multi-Color Has Returned 41.3% Since SmarTrend Recommendation (LABL)
Comtex SmarTrend(R) - Wed Aug 21, 9:13AM CDT
SmarTrend identified an Uptrend for Multi-Color (NASDAQ:LABL) on December 4th, 2012 at $22.97. In approximately 9 months, Multi-Color has returned 41.27% as of today's recent price of $32.45.

Multi-Color Corporation Announces Results for First Quarter of Fiscal Year 2014
Thomson Reuters ONE - Fri Aug 09, 7:30AM CDT
CINCINNATI, OHIO, August 9, 2013 - Multi-Color Corporation (NASDAQ: LABL) announces net revenues increased 1% to $166.8 million from $165.0 million in the prior year. First quarter core earnings per share decreased 13% to $0.48 per diluted share from $0.55 in the prior year quarter. Diluted net earnings per share decreased to $0.40 from $0.49 in the prior year. Non-core items (consisting of integration expenses, acquisition expenses, plant consolidation expenses, purchase accounting charges, and currency losses related to repatriation of foreign currency) increased to $0.08 per share from $0.06 per share in the prior year.

Multi-Color Corporation Completes Flexoprint Acquisition
Thomson Reuters ONE - Thu Aug 01, 1:30PM CDT
CINCINNATI, OHIO - August 1, 2013 - Multi-Color Corporation (NASDAQ: LABL) announced today that the previously announced acquisition of privately held Flexoprint has been completed.

Multi-Color CorporationAnnounces Date of First Quarter Fiscal Year 2014 Financial Results Conference Call and Webcast
Thomson Reuters ONE - Tue Jul 30, 2:30PM CDT
CINCINNATI, OHIO, July 30, 2013 -- Multi-Color Corporation (NASDAQ:LABL) will announce First Quarter Fiscal Year 2014 financial results on Friday, August 9, 2013 at 8:30 a.m. (ET) and hold its quarterly conference call on Friday, August 9, 2013 at 10:00 a.m. (ET) to discuss the news release.

Multi-Color Up 49.2% Since SmarTrend Uptrend Call (LABL)
Comtex SmarTrend(R) - Tue Jul 30, 9:40AM CDT
SmarTrend identified an Uptrend for Multi-Color (NASDAQ:LABL) on December 4th, 2012 at $22.97. In approximately 8 months, Multi-Color has returned 49.15% as of today's recent price of $34.26.

Multi-Color Corporation Acquires Flexo Print in Mexico
Thomson Reuters ONE - Wed Jul 24, 11:01AM CDT
CINCINNATI, OHIO, July 24, 2013 -- Multi-Color Corporation (NASDAQ:LABL) today announces it has entered into an agreement to acquire 100% of Flexo Print S.A. De C.V., based in Guadalajara, Mexico. The acquisition is expected to be completed on 1st August 2013.

Shares of LABL Up 45.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 23, 9:15AM CDT
SmarTrend identified an Uptrend for Multi-Color (NASDAQ:LABL) on December 4th, 2012 at $22.97. In approximately 8 months, Multi-Color has returned 45.41% as of today's recent price of $33.40.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading